What are the payment terms and lead times?

Payment terms include T/T, Western Union, and Money Gram. Lead time is within 15 workdays off-season and about one month during peak season.

How should the product be stored?

The product should be kept out of light and tightly sealed to maintain stability.

GMP Certified OEM High Quality Cns Piracetam Injection 1g.

Name: GMP Certified OEM High Quality Cns Piracetam Injection 1g.
Brand: Guangzhou Sinolead Biotech Co., Ltd.
SKU: 1942238151

Guangdong, ChinaGuangzhou Sinolead Biotech Co., Ltd.

US$0.10

100,000 box

Sample price:US$0.01/piece.Request sample

Product profile

Customization

Available

Quality Standard

Bp, USP

Ctd Dossier

Ready

Model NO.

injection

Documentation

Copp, COA

Factory Certification

GMP

Transport Package

Carton

Specification

Trademark

Sinolead

Origin

China

Production Capacity

100, 000, 000 Per Year

Key features

GMP Certified OEM Production: Manufactured in a GMP certified facility with ready CTD dossier and Copp/COA documentation.

High Quality Piracetam Injection: 1g/5ml clear liquid injection for treating cerebrovascular disease, brain trauma, and memory loss.

Comprehensive Registration Support: We provide packaging design, registration services, and available registration dossiers for clients.

Flexible OEM Customization: Custom quality standards (BP, USP) and packaging design services tailored to client requirements.

Proven Safety Profile: Acute toxicological tests show no death at doses >10g/kg; subacute/chronic tests showed no adverse effects.

Global Export Experience: Exporting since 2005 to North America, Europe, Asia, and Africa with flexible Incoterms (FOB, CIF, etc.).

Fast Lead Time Delivery: Off-season lead time within 15 workdays; peak season lead time approximately one month.

Multiple Payment Options: Accepts T/T, Western Union, Money Gram, and small-amount payments for convenient transactions.

Company profile

Importers and Exporters

Guangzhou Sinolead Biotech Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2005-06-16Nearest Port: Guangzhou, Shenzhen, Hong KongAverage Response Time: ≤15hTerms of Payment: T/T, Western Union, Small-amount payment, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryThe supplier is a pharmaceutical and healthcare product manufacturer with products including glutathione, ceftriaxone sodium, amoxicillin/clavulanate, and customized generics. It reports multiple management, quality, environmental, occupational safety, and pharmaceutical certifications, along with 50 R&D engineers and 50 quality-control staff. Production information confirms several pharmaceutical dosage forms, but does not provide a directly comparable capacity figure. The supplier supports sample-based, flexible, and minor customization, but explicitly lacks ODM services, SDK availability, and recent new-product development. Service procedures exist for supplier approval, assessment, and corrective actions, although records are incomplete; complaint handling has both a clear procedure and follow-up records. It has no overseas warehouse, showroom, agents, branches, or offline trade-show experience. The company states that it has registered hundreds of pharmaceutical and healthcare products worldwide and...

Supplier typeThe supplier is positioned as a pharmaceutical and healthcare manufacturer, with listed products such as injectable ceftriaxone, glutathione, oral suspension, and customized generics. Its stated activities also include supporting product registration and regulatory dossier compliance, indicating a manufacturing-oriented pharmaceutical supplier rather than a general trading-only provider.

CertificationsThe supplier lists a broad range of certifications and management-system standards, including GMP, ISO 9001, ISO 14001, ISO 14000, HACCP, BSCI, OHSAS/OHSMS 18001, and others. The slice identifies certification holdings but does not provide certificate numbers, validity periods, or scope details.

After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records, and it accepts multiple service quotation and payment terms with stated lead times within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, overseas agents or branches, and has no overseas-service country coverage, limiting evidence of localized after-sales support.

R&D capabilityThe supplier reports 50 R&D engineers, but explicitly states that it had no new products during the past year and no available SDK. It also does not provide ODM services, so the evidence shows established R&D staffing but limited demonstrated recent innovation.

Production capacityThe supplier lists production of multiple pharmaceutical products and dosage forms, including tablets, injections, and oral suspension, and identifies pharmaceuticals and customized generics among its product keywords. It also reports 50 quality-control staff, but the provided production-output statement is not a directly usable capacity metric for comparison.

Customization capabilityThe supplier explicitly offers customization from samples, flexible customization, and minor customization. This supports tailored production, although the supplier separately states that it does not provide ODM services.

Product Q&A

Q:What is the product specification and strength?

The product is Piracetam Injection 1g, with a strength of 5ml containing 1g. It is packed as 10 amps per box.

Q:What are the main indications for this injection?

It is suitable for acute and chronic cerebrovascular disease, brain trauma, toxic encephalopathy, memory loss, mild to moderate brain dysfunction, and mental retardation in children.

Q:What customization and documentation services are provided?

We offer OEM services with customizable quality standards (BP, USP), packaging design, registration services, and provide CTD dossiers, Copp, and COA documents.

Q:What are the precautions for patients with bleeding or renal issues?

Use with caution in patients with bleeding risks or severe renal impairment. Dose reduction is needed for mild/moderate renal dysfunction, and it is contraindicated in severe renal impairment.

Q:What is the mechanism of action of Piracetam?

It is a brain metabolism improving drug that promotes ATP, enhances acetylcholine synthesis, improves nerve excitation conduction, and combats brain function damage from physical/chemical factors.